Mara Diaconu

Dr. Mara Diaconu

Carol Davila University of Medicine and Pharmacy, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Dan Cristian PopescuDan Cristian Popescu
Dan Cristian Popescu
Mara DiaconuMara Diaconu
Mara Diaconu
DTDiana Tint
Diana Tint
NANechita Alexandru
Nechita Alexandru
Background and Objectives: Risk stratification in acute heart failure (AHF) remains challenging, particularly in settings where biomarker availability is limited. Echocardiography offers valuable hemodynamic insights, but no single parameter fully captures the complexity of biventricular dysfunction and pressure overload. This study aimed to evaluate a novel echocardiographic index (ViRTUE Index–VTI-RVRA-TAPSE Unified Evaluation) integrating a peak systolic gradient between the right ventricle and right atrium (RV-RA gradient), tricuspid annular plane systolic excursion (TAPSE), the velocity–time integral in the left ventricular outflow tract (VTI LVOT), NT-proBNP (N-terminal pro–B-type Natriuretic Peptide) levels, and in-hospital mortality among patients with AHF. Materials and Methods: We retrospectively analyzed 123 patients admitted with AHF. Echocardiographic evaluation at admission included TAPSE, VTI LVOT, and the RV-RA gradient. An index was calculated as RV−RA gradient TAPSE x VTI LVOT. NT-proBNP levels and in-hospital outcomes were recorded. Statistical analysis included correlation, logistic regression, and ROC curve evaluation. Results: The proposed index showed a significant positive correlation with NT-proBNP values (r = 0.543, p < 0.0001) and good discriminative ability for elevated NT-proBNP (AUC = 0.79). It also correlated with in-hospital mortality (r = 0.193, p = 0.032) and showed moderate prognostic performance (AUC = 0.68). Higher index values were associated with greater mortality risk. Conclusions: This novel index, based on standard echocardiographic measurements, reflects both systolic dysfunction and pressure overload in AHF. Its correlation with NT-proBNP and in-hospital mortality highlights its potential as a practical, accessible bedside tool for early risk stratification, particularly when biomarker testing is unavailable or delayed.

12 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Dan Cristian PopescuDan Cristian Popescu
Dan Cristian Popescu
Mara DiaconuMara Diaconu
Mara Diaconu
DTDiana Tint
Diana Tint
NANechita Alexandru
Nechita Alexandru
Background/Objectives: Acute heart failure (AHF) is a heterogeneous syndrome with phenotype-dependent prognosis. NT-proBNP is the reference biomarker, but standard echocardiographic measures (TAPSE, RV–RA gradient, LVOT VTI) offer only partial prognostic insight. The Virtue Index, defined as (RV–RA gradient)/(TAPSE × LVOT VTI), was introduced to integrate right–left ventricular interaction. This study evaluated its clinical and prognostic performance in AHF and its behavior across ejection-fraction phenotypes. Methods: We retrospectively analyzed 222 patients with AHF; complete data for Virtue calculation were available in 168 (99 HFrEF, 69 HFpEF) patients. HFmrEF patients were excluded from subgroup prognostic analyses. Correlation with NT-proBNP was assessed using Spearman testing with bootstrap intervals, and in-hospital mortality prediction was evaluated using ROC analysis with DeLong comparisons. Results: In HFpEF, the Virtue Index correlated moderately with NT-proBNP (ρ = 0.38, p = 0.002) and showed fair prognostic discrimination (AUC 0.704), similar to the RV–RA gradient (0.724) and higher than TAPSE or LVOT VTI. In HFrEF, correlation was weak (ρ = 0.19, p = 0.06) and predictive accuracy was modest (AUC 0.584), while LVOT VTI performed best (AUC 0.700). NT-proBNP outperformed all echocardiographic parameters in both groups. Conclusions: The Virtue Index reflects integrated hemodynamics and shows phenotype-dependent prognostic value in AHF, being more informative in HFpEF than in HFrEF. Although NT-proBNP remained superior, Virtue may complement biomarker-based risk assessment by offering a rapid, bedside estimate of short-term mortality risk.

6 July 2026 in Eurasian Journal of Medicine and Oncology
Verified
Journal Article
Open access
PDF file
DPDan-Cristian Popescu
Dan-Cristian Popescu
Mara DiaconuMara Diaconu
Mara Diaconu
ANAlexandru-Cristian Nechita
Alexandru-Cristian Nechita
Atherosclerotic coronary artery disease continues to represent a major contributor to worldwide morbidity and mortality. Although conventional cardiovascular risk factors such as hypertension, dyslipidemia, diabetes mellitus, obesity, smoking, and sedentary lifestyle remain central to cardiovascular prevention, increasing attention has been directed toward psychosocial determinants, particularly occupational stress. Work-related stress, commonly conceptualized through the job strain and effort–reward imbalance models, has been associated with a higher incidence of coronary events, although the magnitude and mechanisms of this relationship remain incompletely understood. This review synthesizes current evidence on the relationship between occupational stress and coronary artery disease, drawing on major epidemiological studies and meta-analyses. Persistent occupational stress contributes to cardiovascular dysfunction through multiple interacting mechanisms. These include activation of the hypothalamic–pituitary–adrenal axis and sympathetic nervous system, promotion of systemic inflammatory activity, oxidative stress, autonomic imbalance, and unfavorable behavioral adaptations (e.g., smoking, unhealthy dietary habits, physical inactivity, and excessive alcohol intake). Collectively, these alterations may accelerate endothelial dysfunction, thrombogenicity, and atherosclerotic progression. Key studies, including INTERHEART and meta-analyses by Kivimäki et al., along with prospective data from Chandola et al. on metabolic syndrome, support both independent and cumulative effects of occupational stress on cardiovascular risk. Although its attributable risk is lower than that of traditional risk factors, occupational stress is modifiable, offering significant preventive potential. Intervention strategies include individual approaches (e.g., stress management, lifestyle changes, and psychological support), organizational measures (e.g., improving job control, reducing demands, and enhancing workplace support), and public health policies (e.g., occupational health programs and stress screening). Recognizing occupational stress as a modifiable and clinically relevant contributor to cardiovascular risk has important implications for prevention strategies and public health policies. Future research should prioritize longitudinal studies, biomarker identification, and the evaluation of cost-effective interventions.

17 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Mara DiaconuMara Diaconu
Mara Diaconu
Dan Cristian PopescuDan Cristian Popescu
Dan Cristian Popescu
DTDiana Tint
Diana Tint
NANechita Alexandru
Nechita Alexandru
Background/Objectives: High-sensitivity cardiac troponin T (hs-cTnT) is frequently elevated in decompensated heart failure (DHF), but its prognostic association may vary according to clinical context. We evaluated baseline and serial hs-cTnT in relation to in-hospital mortality across clinical presentation, left ventricular ejection fraction (LVEF) and diabetes status. Methods: A total of 653 patients hospitalized with DHF were prospectively analyzed. Baseline hs-cTnT was assessed globally and across clinical presentation, LVEF and diabetes status. Among 334 patients with repeated measurements, serial hs-cTnT was evaluated using continuous measures and threshold-based trajectories. Results: In-hospital mortality was 9.0%. Baseline hs-cTnT showed moderate discrimination for mortality (AUC 0.658). The internally derived 38.4 pg/mL threshold identified higher mortality above versus below the threshold (14.8% vs. 5.1%, p < 0.001) but showed limited bootstrap stability. Clinical presentation significantly modified the association between hs-cTnT and mortality (global interaction p = 0.022), driven by a stronger association in decompensated right-sided versus left-sided HF (ratio of ORs 2.77, 95% CI 1.26–6.07). No significant modification effect was observed by LVEF or diabetes status. In a serial subgroup, repeated hs-cTnT remained associated with mortality after multivariable adjustment (OR 1.59 per doubling, 95% CI 1.14–2.21), although the increase in discrimination over the baseline model was not significant (AUC 0.750 vs. 0.777, p = 0.205). The above-above trajectory remained associated with mortality in Firth regression (adjusted OR 2.32, 95% CI 1.02–5.61). Conclusions: hs-cTnT was associated with in-hospital mortality in DHF, with heterogeneity by clinical presentation. Serial measurements were associated with outcome, but their incremental discrimination value was limited. Threshold-based trajectories should be considered exploratory pending external validation.

24 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Dan Cristian PopescuDan Cristian Popescu
Dan Cristian Popescu
Mara DiaconuMara Diaconu
Mara Diaconu
DTDiana Tint
Diana Tint
NANechita Alexandru
Nechita Alexandru
Background: Cardiogenic pulmonary edema (CPE) is a severe manifestation of acute heart failure (AHF), typically driven by elevated left ventricular (LV) filling pressures. While LV dysfunction has been the traditional focus, growing evidence highlights the role of right ventricular (RV) impairment and biventricular interaction in the pathophysiology and prognosis of AHF. Objectives: To characterize the clinical and echocardiographic profile of patients presenting with CPE and to assess the comparative prognostic contribution of LV and RV function to in-hospital outcomes. Methods: We retrospectively analyzed 28 patients with CPE from a larger AHF registry, excluding those with incomplete echocardiographic data or missing NT-proBNP measurement. Comprehensive echocardiographic assessment at admission included TAPSE, S RV, RV–RA gradient, LVEF, LVOT VTI, S LV, and E/E′ ratio. Clinical variables, NT-proBNP levels, and in-hospital outcomes (mortality, ventilation, inotropic support, ICU stay) were recorded. Group comparisons, correlation analyses, and ROC curve assessments were performed.Results: The mean S LV was significantly lower than S RV (7.34 ± 2.38 cm/s vs. 11.49 ± 2.70 cm/s; p < 0.001), indicating predominant LV longitudinal systolic impairment. Four patients (14.3%) died during hospitalization. No echocardiographic parameter reached statistical significance for predicting mortality. Patients with higher mitral E velocity and reduced LV systolic velocities tended to have longer ICU hospitalization.Trends toward lower S RV and higher S LV/S RV ratio were noted in patients requiring inotropes.Conclusions: In CPE, LV longitudinal systolic function is more impaired than RV function at presentation. While single echocardiographic indices lacked strong prognostic discrimination in this small cohort, integrated assessment of LV and RV systolic performance alongside diastolic filling pressures may improve early risk stratification. These findings align with the conceptual framework of composite prognostic tools and warrant validation in larger prospective studies.

7 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Dan Cristian PopescuDan Cristian Popescu
Dan Cristian Popescu
Mara DiaconuMara Diaconu
Mara Diaconu
DTDiana Tint
Diana Tint
NANechita Alexandru
Nechita Alexandru
Background/Objectives: Acute heart failure (AHF) is a heterogeneous clinical syndrome, and prognosis varies depending on the ejection fraction phenotype. Although the N-terminal pro–B-type natriuretic peptide (NT-proBNP) remains the benchmark biomarker, conventional echocardiographic measures such as the tricuspid annular plane systolic excursion (TAPSE), the right ventricular to right atrial pressure gradient (RV–RA gradient), and the left ventricular outflow tract velocity–time integral (LVOT VTI) provide only partial prognostic information.We previously proposed the Virtue Index, defined as the ratio between the RV–RA gradient and the product of TAPSE and LVOT VTI, reflecting the interaction between right and left ventricular performance. The present study aimed to assess the clinical and prognostic behavior of the index in a cohort of patients with AHF and to determine whether its performance differs between reduced and preserved ejection fraction phenotypes. Methods: We retrospectively analyzed 222 patients admitted with a diagnosis of AHF. Complete echocardiographic data for Virtue Index calculation were available in 168 patients (99 [59%] with heart failure with reduced ejection fraction [HFrEF] and 69 [41%] with heart failure with preserved ejection fraction [HFpEF]). Patients with mid-range ejection fraction (40–49%) or incomplete echocardiographic parameters were excluded from subgroup analyses but retained for descriptive statistics where applicable. Correlation with NT-proBNP was evaluated using Spearman rank testing with bootstrap confidence intervals. Prognostic performance for in-hospital mortality was analyzed using ROC curves, area under the curve (AUC) with bootstrap intervals, and pairwise DeLong comparisons. Results: In the HFpEF subgroup, the index correlated moderately with NT-proBNP (ρ = 0.38, 95% CI 0.13–0.58, p = 0.002) and demonstrated fair prognostic discrimination (AUC 0.704, 95% CI 0.53–0.85), comparable to the RV–RA gradient (AUC 0.724) and higher than TAPSE (AUC 0.637) or LVOT VTI (AUC 0.669). In contrast, in HFrEF, the index showed a weak, non-significant correlation with NT-proBNP (ρ = 0.19, p = 0.06) and modest predictive accuracy (AUC 0.584, 95% CI 0.36–0.79), while LVOT VTI achieved the best discrimination (AUC 0.700). NT-proBNP remained superior in both subgroups (AUC 0.744 in HFrEF, 0.838 in HFpEF). Conclusions: The Virtue Index reflects integrated haemodynamic function and may demonstrate a phenotype-dependent prognostic role in AHF. In our study, its value was more evident in HFpEF, whereas in HFrEF traditional parameters, especially LVOT VTI, remained stronger predictors. Although NT-proBNP consistently outperformed Virtue, the index may complement biomarker assessment by providing rapid, bedside risk stratification of short-term mortality.